Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
US8299054B2 · kind B2 · utility
0Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2010 |
| Grant date | Oct 30, 2012 |
| Priority date | — |
| Expiry date | Oct 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.